Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris

Cellular Physiology and Biochemistry

Volumn 39, Issue 3, 2016, Pages 837-846

  Li, Hai Yu ^a   Zhao, Xin ^b   Liu, Yu Zhou ^a   Meng, Zhe ^a   Wang, Dan ^a   Yang, Fan ^a   Shi, Qiang Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Biomarkers; Circulating microRNAs; Coronary heart disease

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA 126; TRIACYLGLYCEROL; BIOLOGICAL MARKER; MICRORNA; MIRN126 MICRORNA, HUMAN;

ADULT; ARTICLE; BODY MASS; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; DISEASE COMPLEXITY; DISEASE SEVERITY; DOWN REGULATION; DYSLIPIDEMIA; FEMALE; GENERAL ASPECTS OF DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SMOKING; STABLE ANGINA PECTORIS; SYNTAX SCORE; SYSTOLIC BLOOD PRESSURE; AGE; AGED; BLOOD; CASE CONTROL STUDY; COMPLICATION; DIABETES MELLITUS; DIAGNOSTIC IMAGING; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

AGE FACTORS; AGED; ANGINA, STABLE; BIOMARKERS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84981501479     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000447794     Document Type: Article

References (40)

1. Capodanno D, Capranzano P, Di Salvo ME, Caggegi A, Tomasello D, Cincotta G, Miano M, Patane M, Tamburino C, Tolaro S, Patane L, Calafiore AM, Tamburino C: Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv 2009;2:731-738.
2. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, Colombo A, Morice MC, Dawkins K, de Bruyne B, Kornowski R, de Servi S, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, Wittebols K, Stoll HP, Boersma E, Parrinello G: Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. AM J Cardiol 2007;99:1072-1081.
3. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW: The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. Euro Intervention 2005;1:219-227.
4. Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ: Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective. Heart 2015;101:1980-1988.
5. Widmer RJ, Lerman LO, Lerman A: MicroRNAs: Small molecule, big potential for coronary artery disease. Eur Heart J 2016
6. Berezin A, Zulli A, Kerrigan S, Petrovic D, Kruzliak P: Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Clin Biochem 2015; 48: 562-568.
7. Sato K, Watanabe R, Itoh F, Shichiri M, Watanabe T: Salusins: Potential use as a biomarker for atherosclerotic cardiovascular diseases. Int J Hypertens 2013;2013:965140.
8. van Rooij E: The art of microRNA research. Circ Res 2011;108:219-234.
9. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
10. Romaine SP, Tomaszewski M, Condorelli G, Samani NJ: MicroRNAs in cardiovascular disease: An introduction for clinicians. Heart 2015;101:921-928.
11. Thum T, Condorelli G: Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ Res 2015;116:751-762.
12. Vegter EL, van der Meer P, de Windt LJ, Pinto YM, Voors AA: MicroRNAs in heart failure: From biomarker to target for therapy. Eur J Heart Fail 2016;18:457-48.
13. Tijsen AJ, Pinto YM, Creemers EE: Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 2012;303:H1085-H1095.
14. Li S, Fan Q, He S, Tang T, Liao Y, Xie J: MicroRNA-21 negatively regulates Treg cells through a TGF-beta1/Smad-independent pathway in patients with coronary heart disease. Cell Physiol Biochem 2015;37:866-878.
15. Xu Y, Zhu W, Sun Y, Wang Z, Yuan W, Du Z: Functional network analysis reveals versatile MicroRNAs in human heart. Cell Physiol Biochem 2015;36:1628-1643.
16. Zhao X, Wang K, Liao Y, Zeng Q, Li Y, Hu F, Liu Y, Meng K, Qian C, Zhang Q, Guan H, Feng K, Zhou Y, Du Y, Chen Z: MicroRNA-101a inhibits cardiac fibrosis induced by hypoxia via targeting TGFbetaRI on cardiac fibroblasts. Cell Physiol Biochem 2015;35:213-226.
17. Dumache R, Ciocan V, Muresan C, Rogobete AF, Enache A: Circulating MicroRNAs as promising biomarkers in forensic body fluids identification. Clin Lab 2015;61:1129-1135.
18. Kondkar AA, Abu-Amero KK: Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases. Biomed Res Int 2015;2015:821823.
19. Weber C, Noels H: Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med 2011;17:1410-1422.
20. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008;15:261-271.
21. Long G, Wang F, Duan Q, Chen F, Yang S, Gong W, Wang Y, Chen C, Wang DW: Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci 2012;8:811-818.
22. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S: Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107:677-684.
23. Sun X, Zhang M, Sanagawa A, Mori C, Ito S, Iwaki S, Satoh H, Fujii S: Circulating microRNA-126 in patients with coronary artery disease: Correlation with LDL cholesterol. Thromb J 2012;10:16.
24. Lu H, Daugherty A: Atherosclerosis. Arterioscler Thromb Vasc Biol 2015;35:485-491.
25. Wei Y, Nazari-Jahantigh M, Neth P, Weber C, Schober A: MicroRNA-126, -145, and -155: A therapeutic triad in atherosclerosis? Arterioscler Thromb Vasc Biol 2013;33:449-454.
26. Mocharla P, Briand S, Giannotti G, Dorries C, Jakob P, Paneni F, Luscher T, Landmesser U: AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: Role for proangiogenic effects and alterations in type 2 diabetics. Blood 2013;121:226-236.
27. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D: MiR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008;15:272-284.
28. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ: MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 2008;105:1516-1521.
29. van Solingen C, de Boer HC, Bijkerk R, Monge M, van Oeveren-Rietdijk AM, Seghers L, de Vries MR, van der Veer EP, Quax PH, Rabelink TJ, van Zonneveld AJ: MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)/Lin(-) progenitor cells in ischaemia. Cardiovasc Res 2011;92:449-455.
30. Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H, Hristov M, Wang S, Kiessling F, Olson EN, Weber C: MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 2014;20:368-376.
31. Ren J, Zhang J, Xu N, Han G, Geng Q, Song J, Li S, Zhao J, Chen H: Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. Plos One 2013;8:e80738.
32. Olivieri F, Bonafe M, Spazzafumo L, Gobbi M, Prattichizzo F, Recchioni R, Marcheselli F, La Sala L, Galeazzi R, Rippo MR, Fulgenzi G, Angelini S, Lazzarini R, Bonfigli AR, Bruge F, Tiano L, Genovese S, Ceriello A, Boemi M, Franceschi C, Procopio AD, Testa R: Age-and glycemia-related miR-126-3p levels in plasma and endothelial cells. Aging (Albany NY) 2014;6:771-787.
33. Zhang T, Li L, Shang Q, Lv C, Wang C, Su B: Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Biochem Biophys Res Commun 2015;463:60-63.
34. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M: Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010;107:810-817.
35. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E, Colombo A, Mack MJ, Holmes DJ, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW: Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-Year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381:629-638.
36. Chang TY, Hsu CY, Huang PH, Chiang CH, Leu HB, Huang CC, Chen JW, Lin SJ: Usefulness of circulating decoy receptor 3 in predicting coronary artery disease severity and future major adverse cardiovascular events in patients with multivessel coronary artery disease. Am J Cardiol 2015;116:1028-1033.
37. Arbel Y, Zlotnik M, Halkin A, Havakuk O, Berliner S, Herz I, Rabinovich I, Keren G, Bazan S, Finkelstein A, Banai S: Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography. Clin Res Cardiol 2014;103:223-227.
38. Kose M, Emet S, Akpinar TS, Kocaaga M, Cakmak R, Akarsu M, Yuruyen G, Arman Y, Tukek T: Serum endocan level and the severity of coronary artery disease: A pilot study. Angiology 2015;66:727-731.
39. Gao H, Guddeti RR, Matsuzawa Y, Liu LP, Su LX, Guo D, Nie SP, Du J, Zhang M: Plasma levels of microRNA-145 are associated with severity of coronary artery disease. Plos One 2015;10:e123477.
40. Potus F, Ruffenach G, Dahou A, Thebault C, Breuils-Bonnet S, Tremblay E, Nadeau V, Paradis R, Graydon C, Wong R, Johnson I, Paulin R, Lajoie AC, Perron J, Charbonneau E, Joubert P, Pibarot P, Michelakis ED, Provencher S, Bonnet S: Downregulation of MicroRNA-126 contributes to the failing right ventricle in pulmonary arterial hypertension. Circulation 2015;132:932-943.